REIKI IN THE RELIEF OF CHEMOTHERAPY-RELATED BIOPSYCHOEMOTIONAL SIGNS AND SYMPTOMS

REIKI IN THE RELIEF OF CHEMOTHERAPY-RELATED BIOPSYCHOEMOTIONAL SIGNS AND SYMPTOMS

Objective: verify the use of Reiki in the relief of chemotherapy-related biopsychoemotional signs and symptoms.Method: integrative review guided by the question: Can the use of Reiki relieve some chemotherapy-induced signs and symptoms? The search was undertaken in the databases Virtual Health Libra...

Full description

Bibliographic Details
Main Authors:	Sieglinder Larissa Beulke, Luciana Vannucci, Léia Fortes Salles, Ruth Natalia Teresa Turrini
Format:	Article
Language:	English
Published:	Universidade Federal do Paraná 2019-02-01
Series:	Cogitare Enfermagem
Subjects:	Nursing Care Review Oncology Therapeutic Touch Complementary Therapies
Online Access:	http://dx.doi.org/10.5380/ce.v24i0.56694

Similar Items

Reiki for promotion of health and sleep quality in hospital nursing professionals
by: Josane Rosenilda da Costa, et al.
Published: (2022-08-01)

Self-Reiki, Consideration of a Potential Option for Managing Chronic Pain during Pandemic COVID-19 Period
by: Maxime Billot, et al.
Published: (2021-08-01)

Reiki therapy in the Unified Health System: meanings and experiences in integral health care
by: Mariana Monteiro Amarello, et al.

O uso da terapia reiki nas américas do norte e do sul: uma revisão [Use of reiki therapy in countries of the north and south: a review]
by: José Henrique do Nascimento Bessa, et al.
Published: (2014-03-01)

The Promise and Challenges of Energy Medicine: A Review of the Current Landscape
by: Premalatha BR, et al.
Published: (2023-10-01)

Comprehensive care from the perspective of nurses: an ecosystem approach
by: Rosiane Filipin Rangel, et al.
Published: (2020-12-01)

Postoperative analgesic effects of Reiki therapy in bitches undergoing ovariohysterectomy
by: Leandro Pacheco, et al.
Published: (2021-06-01)

A rapid evidence assessment of recent therapeutic touch research
by: Bernie Garrett, et al.
Published: (2021-09-01)

PREVALENCE OF INTEGRATIVE AND COMPLEMENTARY PRACTICES IN PATIENTS UNDERGOING ANTINEOPLASTIC CHEMOTHERAPY
by: Isabela Oliva Gurgel, et al.
Published: (2019-09-01)

The effect of therapeutic touch on the pain of the women suffering from cancer
by: Aghebati N, et al.
Published: (2007-04-01)

Perception of Touch in the Physiotherapist-Patient Relationship
by: Bystrzycka Karolina, et al.
Published: (2023-06-01)

Transpersonal care through Reiki: Experiences of family members of children with sickle cell disease
by: Amarry Dantas Morbeck, et al.
Published: (2021-12-01)

Effects of Yakson Therapeutic Touch and Heel Warming on Pain Caused by Heel Stick Procedure, Vital Signs, and Cry Duration in Full-term Neonates
by: Mahdie Mir, et al.
Published: (2018-07-01)

Dexrazoxane an allied of nursing in chemotherapy extravasation: Integrative Review
by: Isabelle Pimentel Gomes, et al.
Published: (2009-08-01)

Pengaruh Terapi Touch and Talk Terhadap Kecemasan Anak Usia Pra Sekolah
by: Novia Ika Pratiwi, et al.
Published: (2019-07-01)

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
by: Tara L. Hogenson, et al.
Published: (2022-11-01)

Reiki and Diabetes
by: Ulviye Özcan Yüce, et al.
Published: (2017-07-01)

Effect of therapeutic touch on agitated behavior in elderly patients with dementia: A review
by: Fei-Fei Cai, et al.
Published: (2015-09-01)

THE SITUATION OF THE TEACHING OF HOLISTIC AND COMPLEMENTARY PRACTICES IN UNDERGRADUATE COURSES IN NURSING, PHYSIOTHERAPY AND MEDICINE
by: Léia Fortes Salles, et al.
Published: (2014-12-01)

Quisinostat is a brain-penetrant radiosensitizer in glioblastoma
by: Costanza Lo Cascio, et al.
Published: (2023-11-01)

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
by: Heng Du, et al.
Published: (2023-11-01)

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
by: Quy Le, et al.
Published: (2022-11-01)

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
by: Ashwin Ajith, et al.
Published: (2023-11-01)

Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
by: Arnab Ghosh, et al.
Published: (2022-09-01)

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
by: Ipshita Nandi, et al.
Published: (2023-04-01)

H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
by: Santiago Haase, et al.
Published: (2022-11-01)

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
by: Kun Li, et al.
Published: (2022-11-01)

Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
by: Juan Yan, et al.
Published: (2022-09-01)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
by: Thale Kristin Olsen, et al.
Published: (2022-10-01)

HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis
by: Malay K. Sannigrahi, et al.
Published: (2022-09-01)

Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
by: Jinmei Jin, et al.
Published: (2022-11-01)

A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
by: Devivasha Bordoloi, et al.
Published: (2022-11-01)

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression
by: Sabina Pozzi, et al.
Published: (2022-10-01)

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle
by: Se Jin Oh, et al.
Published: (2022-03-01)

Targeting Gi/o protein–coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy
by: Cancan Lyu, et al.
Published: (2021-09-01)

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis
by: Li-Chung Tsao, et al.
Published: (2022-03-01)

Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma
by: Varsha Ananthapadmanabhan, et al.
Published: (2022-07-01)

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors
by: Nabil Hajji, et al.
Published: (2022-03-01)

HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy
by: Shaima Salman, et al.
Published: (2022-05-01)

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
by: Shigeki Nanjo, et al.
Published: (2022-07-01)